Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetrodotoxin-sensitive voltage-gated sodium channels (TTX-S Nav) are essential transmembrane proteins that mediate the rapid influx of sodium ions required for the initiation and propagation of action potentials in neurons, including those within the dorsal root ganglion (DRG) (Catterall, 2000, Neuron). In the DRG, this functional group primarily comprises the Nav1.1, Nav1.2, Nav1.3, Nav1.6, and Nav1.7 subtypes, which are distinguished by their high affinity for the pufferfish toxin tetrodotoxin (Rush et al., 2007, Journal of Physiology). These channels are pivotal in sensory processing, particularly in the transmission of nociceptive signals from peripheral tissues to the spinal cord (Dib-Hajj et al., 2013, Nature Reviews Neuroscience). Abnormal expression or gain-of-function mutations in TTX-S channels, especially Nav1.7, are directly linked to severe pain disorders such as erythromelalgia and paroxysmal extreme pain disorder (Waxman, 2006, Nature). Pharmacologically, these channels are the primary targets for local anesthetics and several classes of anticonvulsants, which act by blocking the aqueous pore or stabilizing non-conducting states (Goldin, 2001, Annual Review of Physiology). Current therapeutic research focuses on developing subtype-selective inhibitors to treat chronic pain while avoiding the systemic side effects associated with non-selective sodium channel blockade in the heart and central nervous system (Wood et al., 2004, Journal of Neurobiology).
Inhibition of sodium ion influx through the channel pore, often by binding to the local anesthetic receptor site or stabilizing the inactivated state of the channel.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetrodotoxin-sensitive voltage-gated sodium channels (TTX-S Nav channels) (TTX-S Nav channels).